Skip to main content

Table 3 Diagnosis category among 137 new patients at their first tele(oral)medicine visit from April 1 to December 22, 2020

From: The role of telemedicine for symptoms management in oral medicine: a retrospective observational study

Diagnosis category

N

(%)

Presumptive diagnosis n (%)

Reactive

56

40

Fibroma, papilloma, pyogenic granuloma: n = 37 (52%)

Hypersensitivity reactions: n = 2 (3%)

Other: n = 17 (30%)

Autoimmune

31

23

Lichen planus: n = 14 (45%)

Pemphigus/MMP: n = 3 (10%)

RAS: n = 14 (45%)

Orofacial Pain

18

13

Burning mouth syndrome: n = 16 (89%)

TMJ: n = 1 (5.5%)

Myofascial pain: n = 1 (5.5%)

Infection

17

12

Oral candidiasis: n = 8 (47%)

Bacterial infection: n = 1 (6%)

Recurrent HSV infection: n = 2 (12%)

Other: n = 6 (35%)

Neoplasm

9

6

SCC: n = 3 (33%)

Dysplasia: n = 6 (67%)

Other

4

3

Pre-radiation

Metabolic

1

1

IBD related oral ulcer

Pre-neoplastic

1

1

Proliferative leukoplakia

  1. SCC, squamous cell carcinoma; IBD, inflammatory bowel disease; MMP, mucous membrane pemphigoid; RAS, recurrent aphthous stomatitis